Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer

NCT02115594 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Internal decision

Conditions

Breast Cancer

Interventions

DRUG: Fulvestrant
DRUG: Entinostat
DRUG: Placebo

Sponsor

Syndax Pharmaceuticals